iData’s South Korean MIS spinal implants market MedSuite covers 6 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s Australian MIS spinal implants market MedSuite covers 6 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

The Taiwan MIS spinal implants market MedSuite covers 6 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s Chinese MIS spinal implants market MedSuite covers 6 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s global clear aligners MedSuite covers 2 markets including professional and direct-to-consumer. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

Overall, the U.S. urology market was valued at over $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.3% to reach $5 billion by 2028. As the U.S. urology market demand continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the group

iData’s global interventional cardiology MedSuite covers 12 markets including the coronary stent and introducer sheath markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

The global market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVr) devices, transcatheter aortic heart valve implantation (TAVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion (AD) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pump (IABP) devices, patent foramen ovale (PFO) devices, atrial and ventricular septal defect (ASD and VSD) devices, left atrial appendage closure (LAA) devices, preshaped guidewires and cerebral embolic protection devices.

In 2021, the global dental implant and final abutment market size is projected to reach $4.8 billion, with higher demand for dental implants driving the market growth. In spite of COVID-19, the global market size is expected to increase over the forecast period at a CAGR of 11.6% and exceed $6.8 billion in 2027. Currently,

This Global Report Series represents iData’s entire collection of country-level reports in the Global Digital Dentistry market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s publication year: United States (2021) Europe (2021) Australia (2021) China (2021) India

iData’s global operating room equipment MedSuite covers 8 markets including the hybrid and integrated OR, and surgical microscope markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s global video endoscopy MedSuite covers 4 markets including the surgical camera systems market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

In 2020, the global infusion therapy market size was valued at around $7.5 billion, which is a 15% decrease when compared to 2019. In spite of COVID19, the global market size is expected to increase over the forecast period and reach $11.2 billion in 2027. Currently, the majority of the global infusion therapy market share is

In 2020, the global peripheral vascular device market size was valued at $11.9 billion, with over 16 million yearly peripheral vascular procedures performed. The market size is expected to increase at a compound annual growth rate (CAGR) of 5.2% to reach $16.9 billion in 2026. Throughout this medical market research, we analyzed 113 peripheral vascular

iData’s U.S. neurology devices market MedSuite covers 14 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

In 2020, the global neuromodulation device market size was valued at nearly $4.4 billion, with over 230,000 neuromodulation procedures performed every year. The neuromodulation devices market growth is expected to be around 7.6% allowing the market size to approach $7.3 billion in 2026. Throughout this medical market research, we analyzed 13 neuromodulation device companies across